Product image of Nasobec Aqueous (Beclometasone Dipropionate) supplied by GNH India

Nasobec Aqueous

Active Ingredient:
Beclometasone Dipropionate
Origin:
EU

Nasobec Aqueous (Beclometasone Dipropionate)

Beclometasone Dipropionate, the active ingredient in Nasobec Aqueous, is a corticosteroid (glucocorticoid) presented as an aqueous solution for endosinusial nasal use. It treats allergic rhinitis, nasal inflammation and sinusitis in appropriate patient groups.

GNH India supplies Nasobec Aqueous as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teva Uk Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Beclometasone Dipropionate is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages.
  • Allergic rhinitis: reduces nasal congestion, itching and sneezing.
  • Nasal inflammation: decreases mucosal swelling and discharge.
  • Sinusitis: alleviates sinus pressure and improves drainage.

How It Works

  • Beclometasone Dipropionate binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses the production of pro‑inflammatory cytokines, reduces vascular permeability, and limits leukocyte infiltration, resulting in decreased nasal mucosal inflammation.

Side Effects

Adverse reactions may occur with nasal administration of Beclometasone Dipropionate.

Common Side Effects

  • Nasal irritation or burning sensation.
  • Dryness of the nasal mucosa.
  • Epistaxis (nosebleeds).
  • Headache.
  • Altered taste or throat irritation.

Serious or Rare Side Effects

  • Adrenal suppression with prolonged high‑dose use.
  • Development of cataracts or glaucoma.
  • Nasal septum perforation.
  • Opportunistic fungal infection of the nasal passages.
  • Systemic glucocorticoid effects such as hyperglycaemia.

Precautions & Warnings

  • Before using Nasobec Aqueous, consider the following safety measures.
  • Assess for active infection: avoid use in untreated bacterial sinus infection.
  • Monitor for systemic effects: limit duration and dose to reduce risk of adrenal suppression.
  • Use with caution in patients with glaucoma or cataracts: monitor intra‑ocular pressure.
  • Avoid in children under 2 years unless specifically prescribed.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Beclometasone Dipropionate may interact with other medications.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure.
  • Systemic glucocorticoids: additive immunosuppressive effects.
  • Live vaccines: may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., itraconazole): potential increased exposure.
  • Ritonavir or other protease inhibitors: may raise plasma levels.
  • Nasal decongestants: may increase local irritation.

Frequently Asked Questions

Nasobec Aqueous, containing beclometasone dipropionate, is indicated for the management of allergic rhinitis, nasal inflammation and sinusitis. It helps relieve symptoms such as nasal congestion, itching, sneezing, and sinus pressure by reducing local inflammation within the nasal passages.

Beclometasone dipropionate acts as a glucocorticoid receptor agonist. After entering nasal cells, it binds to intracellular receptors, altering gene transcription to suppress pro‑inflammatory cytokines, decrease vascular permeability, and limit leukocyte migration, thereby reducing swelling and mucus production in the nasal mucosa.

The prescribed dose of Nasobec Aqueous is determined by the treating physician based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the specific instructions provided by their healthcare professional and the product labeling.

Safety data for beclometasone dipropionate in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing Nasobec Aqueous to pregnant or nursing individuals. Consultation with a medical professional is essential.

To request Nasobec Aqueous, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasobec Aqueous delivers beclometasone dipropionate in an aqueous solution, offering a rapid onset of action and convenient nasal administration. Compared with other nasal corticosteroids such as fluticasone or mometasone, it provides similar anti‑inflammatory efficacy, though individual response and dosing frequency may vary according to physician preference.

Nasobec Aqueous should be stored at ambient temperature, below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Do not use the product if the solution appears discoloured or contains particles.

Nasobec Aqueous is administered endosinusially via the nasal route. The patient gently tilts the head forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though uncommon, include adrenal suppression with prolonged high‑dose use, development of cataracts or glaucoma, nasal septum perforation, opportunistic fungal infections, and systemic glucocorticoid effects such as hyperglycaemia. Patients should report any unusual symptoms to their healthcare provider promptly.

Nasobec Aqueous should be avoided in individuals with known hypersensitivity to beclometasone dipropionate or any component of the formulation. It is also contraindicated in patients with untreated bacterial, fungal or viral infections of the nasal passages, and in children under the age recommended by the prescriber.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Beclometasone Dipropionate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT